BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Halder J, Pradhan D, Kar B, Ghosh G, Rath G. Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer. Nanomedicine 2021;:102494. [PMID: 34775061 DOI: 10.1016/j.nano.2021.102494] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Pawar CS, Rajendra Prasad N, Yadav P, Muthu Vijayan Enoch IV, Manikantan V, Dey B, Baruah P. Enhanced delivery of quercetin and doxorubicin using β-cyclodextrin polymer to overcome P-glycoprotein mediated multidrug resistance. Int J Pharm 2023;635:122763. [PMID: 36822336 DOI: 10.1016/j.ijpharm.2023.122763] [Reference Citation Analysis]
2 Huang C, Qin L, Chen S, Huang Q. CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression. Anticancer Drugs 2023;34:395-404. [PMID: 36729852 DOI: 10.1097/CAD.0000000000001465] [Reference Citation Analysis]
3 Maher R, Moreno-borrallo A, Jindal D, Mai BT, Ruiz-hernandez E, Harkin A. Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery. Pharmaceutics 2023;15:746. [DOI: 10.3390/pharmaceutics15030746] [Reference Citation Analysis]
4 Liu H, Zhu X, Wei Y, Song C, Wang Y. Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems. Biomed Pharmacother 2023;157:114065. [PMID: 36481408 DOI: 10.1016/j.biopha.2022.114065] [Reference Citation Analysis]
5 Coluzzi F, Scerpa MS, Rocco M, Fornasari D. The Impact of P-Glycoprotein on Opioid Analgesics: What's the Real Meaning in Pain Management and Palliative Care? Int J Mol Sci 2022;23. [PMID: 36430602 DOI: 10.3390/ijms232214125] [Reference Citation Analysis]
6 Chen J, Zhou Q, Lu Y. Saponins from Panax notoginseng ameliorate steroid resistance in lupus nephritis through regulating lymphocyte-derived exosomes in mice. Front Pharmacol 2022;13:946392. [DOI: 10.3389/fphar.2022.946392] [Reference Citation Analysis]
7 Ramalho MJ, Andrade S, Loureiro JA, Pereira MC. Interaction of Bortezomib with Cell Membranes Regulates Its Toxicity and Resistance to Therapy. Membranes 2022;12:823. [DOI: 10.3390/membranes12090823] [Reference Citation Analysis]
8 Feyzizadeh M, Barfar A, Nouri Z, Sarfraz M, Zakeri-Milani P, Valizadeh H. Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery. Expert Opin Drug Discov 2022;:1-15. [PMID: 35996765 DOI: 10.1080/17460441.2022.2112666] [Reference Citation Analysis]
9 Halder J, Pradhan D, Biswasroy P, Rai VK, Kar B, Ghosh G, Rath G. Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer. J Drug Target 2022;:1-21. [PMID: 35786242 DOI: 10.1080/1061186X.2022.2095389] [Reference Citation Analysis]
10 Akbari J, Saeedi M, Ahmadi F, Hashemi SMH, Babaei A, Yaddollahi S, Rostamkalaei SS, Asare-addo K, Nokhodchi A. Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration. Pharmaceutical Development and Technology. [DOI: 10.1080/10837450.2022.2084554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Md S, Alhakamy NA, Sharma P, Ansari MS, Gorain B. Nanocarrier-based co-delivery approaches of chemotherapeutics with natural P-glycoprotein inhibitors in the improvement of multidrug resistance cancer therapy. Journal of Drug Targeting. [DOI: 10.1080/1061186x.2022.2069782] [Reference Citation Analysis]
12 Thapa R, Gurung S, Parat M, Parekh HS, Pandey P. Application of Sol–Gels for Treatment of Gynaecological Conditions—Physiological Perspectives and Emerging Concepts in Intravaginal Drug Delivery. Gels 2022;8:99. [DOI: 10.3390/gels8020099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]